Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study
Top Cited Papers
- 15 February 2006
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 7 (3), 223-229
- https://doi.org/10.1016/s1470-2045(06)70585-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2005
- Knowledge, Attitudes, and Utilization ofBRCA1/2Testing among Women with Early-Onset Breast CancerGenetic Testing, 2005
- Bias in Intervention Studies That Enroll Patients From High-Risk ClinicsJNCI Journal of the National Cancer Institute, 2004
- Prophylactic Mastectomy for BRCA1/2 Carriers: Progress and More QuestionsJournal of Clinical Oncology, 2004
- Potential for Bias in Studies on Efficacy of Prophylactic Surgery for BRCA1 and BRCA2 MutationJNCI Journal of the National Cancer Institute, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2MutationNew England Journal of Medicine, 2002
- Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2MutationsNew England Journal of Medicine, 2002
- The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2Journal of Clinical Oncology, 2002
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996